Why cancer patients enter randomized clinical trials: exploring the factors that influence their decision.

PubWeight™: 1.80‹?› | Rank: Top 3%

🔗 View Article (PMID 15514372)

Published in J Clin Oncol on November 01, 2004

Authors

James R Wright1, Timothy J Whelan, Susan Schiff, Sacha Dubois, Dauna Crooks, Patricia T Haines, Diane DeRosa, Robin S Roberts, Amiram Gafni, Kathleen Pritchard, Mark N Levine

Author Affiliations

1: Juravinski Cancer Centre, 699 Concession St, Hamilton, Ontario L8V 5C2. jim.wright@hrcc.on.ca

Articles citing this

Influence of clinical communication on patients' decision making on participation in clinical trials. J Clin Oncol (2008) 3.17

The attitudes of 1066 patients with cancer towards participation in randomised clinical trials. Br J Cancer (2010) 1.60

Ethics of mandatory research biopsy for correlative end points within clinical trials in oncology. J Clin Oncol (2010) 1.42

Characteristics and outcomes of patients with advanced non-small-cell lung cancer who declined to participate in randomised clinical chemotherapy trials. Br J Cancer (2009) 1.17

The role of health literacy on African American and Hispanic/Latino perspectives on cancer clinical trials. J Cancer Educ (2012) 1.16

Cancer patient decision making related to clinical trial participation: an integrative review with implications for patients' relational autonomy. Support Care Cancer (2015) 1.12

The ethical use of mandatory research biopsies. Nat Rev Clin Oncol (2011) 1.11

Biopsies: next-generation biospecimens for tailoring therapy. Nat Rev Clin Oncol (2013) 1.02

Characteristics and outcomes of patients with advanced gastric cancer who declined to participate in a randomized clinical chemotherapy trial. J Oncol Pract (2011) 1.02

The relationships among knowledge, self-efficacy, preparedness, decisional conflict, and decisions to participate in a cancer clinical trial. Psychooncology (2012) 1.00

The effect of clinical trial participation versus non-participation on overall survival in men receiving first-line docetaxel-containing chemotherapy for metastatic castration-resistant prostate cancer. BJU Int (2012) 1.00

Easy-to-read informed consent forms for hematopoietic cell transplantation clinical trials. Biol Blood Marrow Transplant (2011) 1.00

Enrollment onto breast cancer therapeutic clinical trials: a tertiary cancer center experience. Appl Nurs Res (2013) 0.97

Exploring decision-making of HIV-infected Hispanics and African Americans participating in clinical trials. J Assoc Nurses AIDS Care (2011) 0.93

Cancer patients' fears related to clinical trial participation: a qualitative study. J Cancer Educ (2012) 0.91

Exclusion of older patients from ongoing clinical trials for hematological malignancies: an evaluation of the National Institutes of Health Clinical Trial Registry. Oncologist (2014) 0.91

Effectiveness of strategies to encourage general practitioners to accept an offer of free access to online evidence-based information: a randomised controlled trial. Implement Sci (2009) 0.87

Knowledge, attitudes, and self-efficacy as predictors of preparedness for oncology clinical trials: a mediational model. Med Decis Making (2013) 0.85

Attitudinal barriers to participation in oncology clinical trials: factor analysis and correlates of barriers. Eur J Cancer Care (Engl) (2014) 0.85

Unique perception of clinical trials by Korean cancer patients. BMC Cancer (2012) 0.83

Lung cancer patients' decisions about clinical trials and the theory of planned behavior. J Cancer Educ (2011) 0.81

The Effect of Receiving Treatment Within a Clinical Trial Setting on Survival and Quality of Care Perception in Advanced Stage Non-Small Cell Lung Cancer. Am J Clin Oncol (2016) 0.78

Contributing to research via biobanks: what it means to cancer patients. Health Expect (2012) 0.78

Food environments are relevant to recruitment and adherence in dietary modification trials. Nutr Res (2015) 0.77

Improving clinical trial accrual by streamlining the referral process. Int J Med Inform (2014) 0.77

Will they participate? Predicting patients' response to clinical trial invitations in a pediatric emergency department. J Am Med Inform Assoc (2016) 0.76

A study of motivations and expectations of patients seen in phase 1 oncology clinics. Cancer (2016) 0.75

Participants' perception of pharmaceutical clinical research: a cross-sectional controlled study. Patient Prefer Adherence (2016) 0.75

Barriers and facilitators to recruitment to a culturally-based dietary intervention among urban Hispanic breast cancer survivors. J Racial Ethn Health Disparities (2014) 0.75

Socioeconomic and clinical factors are key to uncovering disparity in accrual onto therapeutic trials for breast cancer. J Natl Compr Canc Netw (2014) 0.75

Knowledge and attitudes regarding medical research studies among patients with breast cancer and gynecological diseases. BMC Cancer (2015) 0.75

Exploring research participation among cancer patients: analysis of a national survey and an in-depth interview study. BMC Cancer (2015) 0.75

Participant preferences for the provision of registration trials results. J Clin Med Res (2013) 0.75

Focus on You: Cancer clinical trials perspectives. Contemp Clin Trials Commun (2016) 0.75

Articles by these authors

Low-molecular-weight heparin versus a coumarin for the prevention of recurrent venous thromboembolism in patients with cancer. N Engl J Med (2003) 11.00

Prophylactic use of an implantable cardioverter-defibrillator after acute myocardial infarction. N Engl J Med (2004) 10.02

American Society of Clinical Oncology technology assessment on the use of aromatase inhibitors as adjuvant therapy for postmenopausal women with hormone receptor-positive breast cancer: status report 2004. J Clin Oncol (2004) 6.59

Randomized trial of long-term follow-up for early-stage breast cancer: a comparison of family physician versus specialist care. J Clin Oncol (2006) 6.24

Caffeine therapy for apnea of prematurity. N Engl J Med (2006) 5.97

What matters most in end-of-life care: perceptions of seriously ill patients and their family members. CMAJ (2006) 5.70

Evaluating survivorship care plans: results of a randomized, clinical trial of patients with breast cancer. J Clin Oncol (2011) 5.67

Prospective Validation of a 21-Gene Expression Assay in Breast Cancer. N Engl J Med (2015) 5.57

Venous thromboembolism prophylaxis and treatment in patients with cancer: American Society of Clinical Oncology clinical practice guideline update. J Clin Oncol (2013) 5.56

American Society of Clinical Oncology guideline: recommendations for venous thromboembolism prophylaxis and treatment in patients with cancer. J Clin Oncol (2007) 5.36

HER2 and responsiveness of breast cancer to adjuvant chemotherapy. N Engl J Med (2006) 5.10

A randomized trial of planned cesarean or vaginal delivery for twin pregnancy. N Engl J Med (2013) 5.06

Less-tight versus tight control of hypertension in pregnancy. N Engl J Med (2015) 5.03

Regional Nodal Irradiation in Early-Stage Breast Cancer. N Engl J Med (2015) 4.94

Long-term results of hypofractionated radiation therapy for breast cancer. N Engl J Med (2010) 4.63

The Premature Infants in Need of Transfusion (PINT) study: a randomized, controlled trial of a restrictive (low) versus liberal (high) transfusion threshold for extremely low birth weight infants. J Pediatr (2006) 4.63

Effect of a decision aid on knowledge and treatment decision making for breast cancer surgery: a randomized trial. JAMA (2004) 4.18

Pacemaker therapy for prevention of syncope in patients with recurrent severe vasovagal syncope: Second Vasovagal Pacemaker Study (VPS II): a randomized trial. JAMA (2003) 3.93

Accelerated partial breast irradiation consensus statement from the American Society for Radiation Oncology (ASTRO). Int J Radiat Oncol Biol Phys (2009) 3.91

Comparison of beta-blockers, amiodarone plus beta-blockers, or sotalol for prevention of shocks from implantable cardioverter defibrillators: the OPTIC Study: a randomized trial. JAMA (2006) 3.84

Long-term effects of caffeine therapy for apnea of prematurity. N Engl J Med (2007) 3.73

Randomized comparison of low molecular weight heparin and coumarin derivatives on the survival of patients with cancer and venous thromboembolism. J Clin Oncol (2005) 3.42

Multiple courses of antenatal corticosteroids for preterm birth (MACS): a randomised controlled trial. Lancet (2008) 3.41

Randomized, double-blind, placebo-controlled trial of erythropoietin in non-small-cell lung cancer with disease-related anemia. J Clin Oncol (2007) 3.12

Quality of life of individuals with heart failure: a randomized trial of the effectiveness of two models of hospital-to-home transition. Med Care (2002) 3.05

Positron emission tomography in staging early lung cancer: a randomized trial. Ann Intern Med (2009) 2.88

Long-term effects of caffeine therapy for apnea of prematurity on sleep at school age. Am J Respir Crit Care Med (2014) 2.82

Helping patients with type 2 diabetes mellitus make treatment decisions: statin choice randomized trial. Arch Intern Med (2007) 2.82

Beyond the development of quality-of-life instruments: where do we go from here? J Clin Oncol (2002) 2.81

Requirements for physicians in 2030: why population aging matters less than you may think. CMAJ (2003) 2.73

Heat Loss Prevention (HeLP) in the delivery room: A randomized controlled trial of polyethylene occlusive skin wrapping in very preterm infants. J Pediatr (2004) 2.73

Effects of targeting higher vs lower arterial oxygen saturations on death or disability in extremely preterm infants: a randomized clinical trial. JAMA (2013) 2.73

Impact of bronchopulmonary dysplasia, brain injury, and severe retinopathy on the outcome of extremely low-birth-weight infants at 18 months: results from the trial of indomethacin prophylaxis in preterms. JAMA (2003) 2.70

The global breast cancer burden: variations in epidemiology and survival. Clin Breast Cancer (2005) 2.69

Venous thromboembolism and cancer: risks and outcomes. Circulation (2003) 2.68

Randomized trial of tamoxifen versus combined tamoxifen and octreotide LAR Therapy in the adjuvant treatment of early-stage breast cancer in postmenopausal women: NCIC CTG MA.14. J Clin Oncol (2011) 2.58

Hemorrhagic complications of anticoagulant and thrombolytic treatment: American College of Chest Physicians Evidence-Based Clinical Practice Guidelines (8th Edition). Chest (2008) 2.54

Helping patients make informed choices: a randomized trial of a decision aid for adjuvant chemotherapy in lymph node-negative breast cancer. J Natl Cancer Inst (2003) 2.51

Ten-year multi-institutional results of breast-conserving surgery and radiotherapy in BRCA1/2-associated stage I/II breast cancer. J Clin Oncol (2006) 2.49

Survival without disability to age 5 years after neonatal caffeine therapy for apnea of prematurity. JAMA (2012) 2.46

Effectiveness of home visitation by public-health nurses in prevention of the recurrence of child physical abuse and neglect: a randomised controlled trial. Lancet (2005) 2.46

Low molecular weight heparin, therapy with dalteparin, and survival in advanced cancer: the fragmin advanced malignancy outcome study (FAMOUS). J Clin Oncol (2004) 2.43

A shared treatment decision-making approach between patients with chronic conditions and their clinicians: the case of diabetes. Health Expect (2006) 2.30

Outcomes of children at 2 years after planned cesarean birth versus planned vaginal birth for breech presentation at term: the International Randomized Term Breech Trial. Am J Obstet Gynecol (2004) 2.26

Treatment decision aids: conceptual issues and future directions. Health Expect (2005) 2.25

Are cancer-related decision aids effective? A systematic review and meta-analysis. J Clin Oncol (2009) 2.24

Assessment of quality of life in MA.17: a randomized, placebo-controlled trial of letrozole after 5 years of tamoxifen in postmenopausal women. J Clin Oncol (2005) 2.20

Multiple courses of antenatal corticosteroids for preterm birth study: outcomes in children at 5 years of age (MACS-5). JAMA Pediatr (2013) 2.18

Assessing the volume-outcome hypothesis and region-level quality improvement interventions: pancreas cancer surgery in two Canadian Provinces. Ann Surg Oncol (2010) 2.16

Effect on birth outcomes of a formalised approach to care in hospital labour assessment units: international, randomised controlled trial. BMJ (2008) 2.11

A new perspective on competencies for self-directed learning. J Nurs Educ (2002) 2.08

Neurosensory impairment after surgical closure of patent ductus arteriosus in extremely low birth weight infants: results from the Trial of Indomethacin Prophylaxis in Preterms. J Pediatr (2007) 2.07

Economists' dream or nightmare? Maximizing health gains from available resources using the NICE guidelines. Health Econ Policy Law (2007) 2.06

Randomized phase II study comparing two schedules of everolimus in patients with recurrent/metastatic breast cancer: NCIC Clinical Trials Group IND.163. J Clin Oncol (2009) 2.04

Optimizing a portfolio of health care programs in the presence of uncertainty and constrained resources. Soc Sci Med (2003) 2.01

Interim cosmetic and toxicity results from RAPID: a randomized trial of accelerated partial breast irradiation using three-dimensional conformal external beam radiation therapy. J Clin Oncol (2013) 1.99

Cyclophosphamide, epirubicin, and Fluorouracil versus dose-dense epirubicin and cyclophosphamide followed by Paclitaxel versus Doxorubicin and cyclophosphamide followed by Paclitaxel in node-positive or high-risk node-negative breast cancer. J Clin Oncol (2009) 1.99

A randomized controlled trial comparing the frequency of acute reactions to plasma-removed platelets and prestorage WBC-reduced platelets. Transfusion (2002) 1.98

Shared treatment decision making: what does it mean to physicians? J Clin Oncol (2003) 1.97

The relationships of left ventricular ejection fraction, end-systolic volume index and infarct size to six-month mortality after hospital discharge following myocardial infarction treated by thrombolysis. J Am Coll Cardiol (2002) 1.96

Indomethacin prophylaxis, patent ductus arteriosus, and the risk of bronchopulmonary dysplasia: further analyses from the Trial of Indomethacin Prophylaxis in Preterms (TIPP). J Pediatr (2006) 1.95

Effectiveness of nurses as providers of birth labor support in North American hospitals: a randomized controlled trial. JAMA (2002) 1.94

The importance of reporting patient recruitment details in phase III trials. J Clin Oncol (2006) 1.92

NCCN Task Force Report: Adjuvant Therapy for Breast Cancer. J Natl Compr Canc Netw (2006) 1.88

Maternal outcomes at 2 years after planned cesarean section versus planned vaginal birth for breech presentation at term: the international randomized Term Breech Trial. Am J Obstet Gynecol (2004) 1.83

Accelerated partial breast irradiation consensus statement from the American Society for Radiation Oncology (ASTRO). J Am Coll Surg (2009) 1.76

Conceptualizing and validating the human services integration measure. Int J Integr Care (2004) 1.75

Hospital and home chemotherapy for children with leukemia: a randomized cross-over study. Pediatr Blood Cancer (2006) 1.72

An improved definition of immune heparin-induced thrombocytopenia in postoperative orthopedic patients. Arch Intern Med (2003) 1.70

The risks of waiting for cardiac catheterization: a prospective study. CMAJ (2002) 1.70

Incidence, risk factors, and outcomes of catheter-related thrombosis in adult patients with cancer. J Clin Oncol (2006) 1.67

Self-reported use of shared decision-making among breast cancer specialists and perceived barriers and facilitators to implementing this approach. Health Expect (2004) 1.67

Cardiovascular outcomes with atrial-based pacing compared with ventricular pacing: meta-analysis of randomized trials, using individual patient data. Circulation (2006) 1.67

Evaluation of metformin in early breast cancer: a modification of the traditional paradigm for clinical testing of anti-cancer agents. Breast Cancer Res Treat (2010) 1.65

American Society of Clinical Oncology technology assessment working group update: use of aromatase inhibitors in the adjuvant setting. J Clin Oncol (2003) 1.64

Role of the implantable defibrillator among elderly patients with a history of life-threatening ventricular arrhythmias. Eur Heart J (2007) 1.63

Sertraline and/or interpersonal psychotherapy for patients with dysthymic disorder in primary care: 6-month comparison with longitudinal 2-year follow-up of effectiveness and costs. J Affect Disord (2002) 1.63

The American Society for Therapeutic Radiology and Oncology (ASTRO) evidence-based review of the role of radiosurgery for brain metastases. Int J Radiat Oncol Biol Phys (2005) 1.59

Prospective study of 2-[¹⁸F]fluorodeoxyglucose positron emission tomography in the assessment of regional nodal spread of disease in patients with breast cancer: an Ontario clinical oncology group study. J Clin Oncol (2012) 1.58

Sex differences in hospital admissions from emergency departments in asthmatic adults: a population-based study. Ann Allergy Asthma Immunol (2006) 1.57

Outcomes at 3 months after planned cesarean vs planned vaginal delivery for breech presentation at term: the international randomized Term Breech Trial. JAMA (2002) 1.56

Funding oncology clinical trials: are cooperative group trials sustainable? J Clin Oncol (2012) 1.56

Exploring the effects of population change on the costs of physician services. J Health Econ (2002) 1.55

Randomized trial of decongestive lymphatic therapy for the treatment of lymphedema in women with breast cancer. J Clin Oncol (2013) 1.54

A prospective evaluation of positron emission tomography scanning, sentinel lymph node biopsy, and standard axillary dissection for axillary staging in patients with early stage breast cancer. Ann Surg Oncol (2004) 1.54

Shared decision making in the medical encounter: are we all talking about the same thing? Med Decis Making (2007) 1.53

Understanding cardiopulmonary resuscitation decision making: perspectives of seriously ill hospitalized patients and family members. Chest (2006) 1.53

Positive end-expiratory pressure above lower inflection point minimizes influx of activated neutrophils into lung. Crit Care Med (2004) 1.52

Using a count of neonatal morbidities to predict poor outcome in extremely low birth weight infants: added role of neonatal infection. Pediatrics (2009) 1.50

Neurodevelopmental outcome of extremely low birth weight infants randomly assigned to restrictive or liberal hemoglobin thresholds for blood transfusion. Pediatrics (2009) 1.50

Heparin-induced skin lesions and other unusual sequelae of the heparin-induced thrombocytopenia syndrome: a nested cohort study. Chest (2005) 1.49

Responsiveness of intrinsic subtypes to adjuvant anthracycline substitution in the NCIC.CTG MA.5 randomized trial. Clin Cancer Res (2012) 1.47